Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain

Virology

Volumn 328, Issue 1, 2004, Pages 62-73

  Bu, Zhigao ^a   Ye, Ling ^b   Vzorov, Andrei ^b   Taylor, Dahnide ^b   Compans, Richard W ^b   Yang, Chinglai ^b  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; SERINE; TYROSINE; VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CODON; CYTOPLASM; ENDOCYTOSIS; GENE CONSTRUCT; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; T LYMPHOCYTE; WILD TYPE;

AIDS VACCINES; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CELL COUNT; CELLS, CULTURED; CYTOPLASM; ENDOCYTOSIS; FEMALE; HIV; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; IMMUNIZATION; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, TERTIARY; SERINE; SPLEEN; T-LYMPHOCYTES; TYROSINE; VACCINES, DNA;

HUMAN IMMUNODEFICIENCY VIRUS; MAMMALIA;

EID: 4544248685     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.06.041     Document Type: Article

References (54)

1. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'nell, S.I. Staprans, D.C. Montefiori, Y. Xu, J.G. Herndon, L.S. Wyatt, M.A. Candido, N.L. Kozyr, P.L. Earl, J.M. Smith, H.L. Ma, B.D. Grimm, M. Hulsey, J. Miller, H.M. McClure, J.M. McNicholl, B. Moss, and H.L. Robinson Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 2001 69 74
2. S. Andre, B. Seed, J. Eberle, W. Schraut, A. Bultmann, and J. Haas Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage J. Virol. 72 1998 1497 1503
3. J.M. Ball, M.J. Mulligan, and R.W. Compans Basolateral sorting of the HIV type 2 and SIV envelope glycoproteins in polarized epithelial cells: role of the cytoplasmic domain AIDS Res. Hum. Retroviruses 13 1997 665 675
4. C. Berlioz-Torrent, B.L. Shacklett, L. Erdtmann, L. Delamarre, I. Bouchaert, P. Sonigo, M.C. Dokhelar, and R. Benarous Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins J. Virol. 73 1999 1350 1361
5. M. Boge, S. Wyss, J.S. Bonifacino, and M. Thali A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor J. Biol. Chem. 273 1998 15773 15778
6. Z. Bu, L. Ye, M.J. Skeen, H.K. Ziegler, R.W. Compans, and C. Yang Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O AIDS Res. Hum. Retroviruses 19 5 2003 409 420
7. A. Bultmann, W. Muranyi, B. Seed, and J. Haas Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression J. Virol. 75 2001 5263 5276
8. G. Cervantes-Acosta, R. Lodge, G. Lemay, and E.A. Cohen Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions J. Hum. Virol. 4 2001 249 259
9. G.B. Cohen, R.T. Gandhi, D.M. Davis, O. Mandelboim, B.K. Chen, J.L. Strominger, and D. Baltimore The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells Immunity 10 1999 661 671
10. K.L. Collins, B.K. Chen, S.A. Kalams, B.D. Walker, and D. Baltimore HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes Nature 391 1998 397 401
11. P. Cosson Direct interaction between the envelope and matrix proteins of HIV-1 EMBO J. 15 1996 5783 5788
12. J.R. Day, C. Munk, and J.C. Guatelli The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity J. Virol. 78 2004 1069 1079
13. C.A. Derdeyn, J.M. Decker, J.N. Sfakianos, X. Wu, W.A. O'Brien, L. Ratner, J.C. Kappes, G.M. Shaw, and E. Hunter Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120 J.Virol. 74 2000 8358 8367
14. J. Deschambeault, J.P. Lalonde, G. Cervantes-Acosta, R. Lodge, E.A. Cohen, and G. Lemay Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission J. Virol. 73 1999 5010 5017
15. R.W. Doms, and J.P. Moore HIV-1 membrane fusion: targets of opportunity J. Cell Biol. 151 2000 F9 F14
16. T. Dorfman, F. Mammano, W.A. Haseltine, and H.G. Gottlinger Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein J. Virol. 68 1994 1689 1696
17. P.L. Earl, R.W. Doms, and B. Moss Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein Proc. Natl. Acad. Sci. U.S.A. 87 1990 648 652
18. M. Facke, A. Janetzko, R.L. Shoeman, and H.G. Krausslich A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum J. Virol. 67 1993 4972 4980
19. D.M. Fernandes, L. Vidard, and K.L. Rock Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments Eur. J. Immunol. 30 2000 2333 2343
20. E.O. Freed, and M.A. Martin The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection J. Biol. Chem. 270 1995 23883 23886
21. P.N. Fultz, P.J. Vance, M.J. Endres, B. Tao, J.D. Dvorin, I.C. Davis, J.D. Lifson, D.C. Montefiori, M. Marsh, M.H. Malim, and J.A. Hoxie In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail J. Virol. 75 2001 278 291
22. R. Geleziunas, W. Xu, K. Takeda, H. Ichijo, and W.C. Greene HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell Nature 410 2001 834 838
23. J. Haas, E.C. Park, and B. Seed Codon usage limitation in the expression of HIV-1 envelope glycoprotein Curr. Biol. 6 1996 315 324
24. O.K. Haffar, G.R. Nakamura, and P.W. Berman The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell lines J. Virol. 64 1990 3100 3103
25. E. Hunter, and R. Swanstrom Retrovirus envelope glycoproteins Curr. Top. Microbiol. Immunol. 157 1990 187 253
26. H. Ishikawa, M. Sasaki, S. Noda, and Y. Koga Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin J. Virol. 72 1998 6574 6580
27. C.C. LaBranche, M.M. Sauter, B.S. Haggarty, P.J. Vance, J. Romano, T.K. Hart, P.J. Bugelski, and J.A. Hoxie Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus J. Virol. 68 1994 5509 5522
28. C.C. LaBranche, M.M. Sauter, B.S. Haggarty, P.J. Vance, J. Romano, T.K. Hart, P.J. Bugelski, M. Marsh, and J.A. Hoxie A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells J. Virol. 69 1995 5217 5227
29. N.L. Letvin, B.R. Bloom, and S.L. Hoffman Prospects for vaccines to protect against AIDS, tuberculosis, and malaria JAMA 285 2001 606 611
30. R. Lodge, H. Gottlinger, D. Gabuzda, E.A. Cohen, and G. Lemay The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells J. Virol. 68 1994 4857 4861
31. R. Lodge, J.P. Lalonde, G. Lemay, and E.A. Cohen The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells EMBO J. 16 1997 695 705
32. A. Mangasarian, V. Piguet, J.K. Wang, Y.L. Chen, and D. Trono Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking J. Virol. 73 1999 1964 1973
33. M. Marsh, and A. Pelchen-Matthews Endocytosis in viral replication Traffic 1 2000 525 532
34. M.A. Miller, T.A. Mietzner, M.W. Cloyd, W.G. Robey, and R.C. Montelaro Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein AIDS Res. Hum. Retroviruses 11 1993 1057 1066
35. G.J. Nabel Challenges and opportunities for development of an AIDS vaccine Nature 410 2001 1002 1007
36. H. Ohno, R.C. Aguilar, M.C. Fournier, S. Hennecke, P. Cosson, and J.S. Bonifacino Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family Virology 238 1997 305 315
37. J.T. Qiu, B. Liu, C. Tian, G.N. Pavlakis, and X.F. Yu Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway J. Virol. 74 2000 5997 6005
38. E. Raz, H. Tighe, Y. Sato, M. Corr, J.A. Dudler, M. Roman, S.L. Swain, H.L. Spiegelberg, and D.A. Carson Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization Proc. Natl. Acad. Sci. U.S.A. 93 1996 5141 5145
39. S. Romagnani The Th1/Th2 paradigm Immunol. Today 18 1997 263 266
40. N.F. Rose, P.A. Marx, A. Luckay, D.F. Nixon, W.J. Moretto, S.M. Donahoe, D. Montefiori, A. Roberts, L. Buonocore, and J.K. Rose An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants Cell 106 2001 539 549
41. I. Rousso, M.B. Mixon, B.K. Chen, and P.S. Kim Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity Proc. Natl. Acad. Sci. U.S.A. 97 2000 13523 13525
42. J.F. Rowell, P.E. Stanhope, and R.F. Siliciano Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC J. Immunol. 155 1995 473 488
43. M.M. Sauter, A. Pelchen-Matthews, R. Bron, M. Marsh, C.C. LaBranche, P.J. Vance, J. Romano, B.S. Haggarty, T.K. Hart, W.M. Lee, and J.A. Hoxie An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface J. Cell Biol. 132 1996 795 811
44. O. Schwartz, V. Marechal, S. Le Gall, F. Lemonnier, and J.M. Heard Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein Nat. Med. 2 1996 338 342
45. J.W. Shiver, T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, R.K. Evans, Z.Q. Zhang, A.J. Simon, W.L. Trigona, S.A. Dubey, L. Huang, V.A. Harris, R.S. Long, X. Liang, L. Handt, W.A. Schleif, L. Zhu, D.C. Freed, N.V. Persaud, L. Guan, K.S. Punt, A. Tang, M. Chen, K.A. Wilson, K.B. Collins, G.J. Heidecker, V.R. Fernandez, H.C. Perry, J.G. Joyce, K.M. Grimm, J.C. Cook, P.M. Keller, D.S. Kresock, H. Mach, R.D. Troutman, L.A. Isopi, D.M. Williams, Z. Xu, K.E. Bohannon, D.B. Volkin, D.C. Montefiori, A. Miura, G.R. Krivulka, M.A. Lifton, M.J. Kuroda, J.E. Schmitz, N.L. Letvin, M.J. Caulfield, A.J. Bett, R. Youil, D.C. Kaslow, and E.A. Emini Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 2002 331 335
46. A.N. Vzorov, and R.W. Compans Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization J. Virol. 74 2000 8219 8225
47. J.T. West, S.K. Weldon, S. Wyss, X. Lin, Q. Yu, M. Thali, and E. Hunter Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation J. Virol. 76 2002 3338 3349
48. R. Wyatt, and J. Sodroski The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens Science 280 1998 1884 1888
49. S. Wyss, C. Berlioz-Torrent, M. Boge, G. Blot, S. Honing, R. Benarous, and M. Thali The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor J. Virol. 75 2001 2982 2992
50. X.N. Xu, B. Laffert, G.R. Screaton, M. Kraft, D. Wolf, W. Kolanus, J. Mongkolsapay, A.J. McMichael, and A.S. Baur Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain J. Exp. Med. 189 1999 1489 1496
51. C. Yang, and R.W. Compans Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide J. Virol. 70 1996 248 254
52. C. Yang, C.P. Spies, and R.W. Compans The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated Proc. Natl. Acad. Sci. U.S.A. 92 1995 9871 9875
53. X. Yu, X. Yuan, M.F. McLane, T.H. Lee, and M. Essex Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions J. Virol. 67 1993 213 221
54. J. zur Megede, M.C. Chen, B. Doe, M. Schaefer, C.E. Greer, M. Selby, G.R. Otten, and S.W. Barnett Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene J. Virol. 74 2000 2628 2635